Glaucoma: open trials in United States

• NCT05344274

  Retinal Blood Flow and Autoregulation

  Trial Treatment · Phase 4 · University of Maryland, Baltimore

  University of Maryland Faculty Physicians, Inc, Baltimore · University of Maryland Medical Center, Baltimore · University of Maryland, Baltimore, Baltimore · Food and Drug Administration (FDA), Silver Spring

  Registry updated 2025-12-02

• NCT07209410

  Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma

  Trial Treatment · Phase 4 · Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,

  Vision Source, Kansas City

  Registry updated 2025-11-18

• NCT07228221

  Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma

  Trial Treatment · Phase 4 · Jonathon Myers

  Wills Eye Hosital Glaucoma Dept., Philadelphia

  Registry updated 2025-11-14

• NCT03933631

  Pilocarpine Use After Kahook Goniotomy

  Trial Treatment · Phase 3 · Montefiore Medical Center

  Montefiore Medical Center, The Bronx · Montefiore Wakefield Campus, The Bronx

  Registry updated 2025-11-10

• NCT00221897

  Diagnostic Innovations in Glaucoma Study

  Research · University of California, San Diego

  UCSD, Hamilton Glaucoma Center, La Jolla

  Registry updated 2025-10-24

• NCT07218783

  Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)

  Trial Treatment · Phase 3 · SpyGlass Pharma, Inc.

  Houston Eye Associates, Houston

  Registry updated 2025-10-20

• NCT07218796

  Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)

  Trial Treatment · Phase 3 · SpyGlass Pharma, Inc.

  R and R Eye Research, LLC, San Antonio

  Registry updated 2025-10-20

• NCT07147647

  Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma

  Trial Treatment · Select Eye Care

  Select Eye Care, Elkridge

  Registry updated 2025-08-29

• NCT07076303

  A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients

  Research · Brian Shafer

  Shafer Vision Institute, Plymouth Meeting

  Registry updated 2025-07-22

• NCT07048886

  Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)

  Trial Treatment · Phase 4 · Center for Sight Las Vegas

  Center for Sight, Las Vegas

  Registry updated 2025-07-03

• NCT06023927

  Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness

  Research · Northwell Health

  Manhattan Eye, Ear & Throat Hospital, New York

  Registry updated 2025-06-10

• NCT06883123

  Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost

  Trial Treatment · Phase 4 · Prairie Eye Center

  Prairie Eye Center, Springfield

  Registry updated 2025-05-15

• NCT06963684

  Glaucoma Laser Assessment of Stability and Sustainability

  Trial Treatment · Twin Cities Eye Consultants

  Twin Cities Eye Consultants, Coon Rapids

  Registry updated 2025-05-14

• NCT06953349

  Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis

  Research · Barnet Dulaney Perkins Eye Centers

  Barnet Dulaney Perkins Eye Center, Mesa

  Registry updated 2025-05-01

• NCT05564091

  Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma

  Trial Treatment · Nova Eye, Inc.

  Berkeley Eye Center, Sugar Land

  Registry updated 2025-04-18

• NCT06933836

  DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

  Research · Barnet Dulaney Perkins Eye Centers

  Barnet Dulaney Perkins Eye Centers, Mesa

  Registry updated 2025-04-18

• NCT06809647

  A Prospective Interventional Cohort Study to Evaluate the Efficacy and Safety of the AquaLumen, a Novel Filtration Procedure for the Treatment of Open Angle Glaucoma

  Trial Treatment · PLU Ophthalmic

  MUSC Storm Eye Institute, Charleston

  Registry updated 2025-02-05

• NCT06693882

  Electrical Stimulation of the Optic Nerve in Patients With Glaucoma.

  Trial Treatment · Glaucoma Center of San Francisco

  Glaucoma Center of San Francisco, San Francisco

  Registry updated 2024-11-20

• NCT00286637

  Novel Glaucoma Diagnostics

  Research · Wills Eye

  Wills Eye Hospital, Philadelphia

  Registry updated 2024-08-15

• NCT06057051

  Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

  Trial Treatment · Glaukos Corporation

  Cincinnati

  Registry updated 2023-09-28

• NCT05844384

  Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

  Trial Treatment · 59th Medical Wing

  Wilford Hall Ambulatory Surgical Center, Lackland Air Force Base

  Registry updated 2023-05-06

• NCT05401357

  Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

  Trial Treatment · Phase 3 · Amneal Pharmaceuticals, LLC

  Keystone Research, Austin · Cheyenne Eye Clinic & Surgery Center, Cheyenne · Houston Eye Associates, North Loop, Houston · Clayton Eye Clinical Research, LLC, Morrow · Toyos Clinic, Nashville · Eye Research Foundation Inc., Newport Beach · Volusia Eye Associates, New Smyrna Beach · North Bay Eye Associates, Inc., Petaluma · Coastal Research Associates, LLC, Roswell

  Registry updated 2022-08-10

All Glaucoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error